Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 28;11(6):1368-1376.
doi: 10.14218/JCTH.2022.00107. Epub 2023 Jun 14.

Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis

Sisi Chen  1 , Xiangying Zhang  1 , Ling Xu  1 , Yuan Tian  1 , Zihao Fan  1 , Yaling Cao  1 , Zhenzhen Pan  1 , Yao Gao  1 , Sujun Zheng  2 , Zhongping Duan  3 , Mei Liu  4 , Feng Ren  1
Affiliations

Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis

Sisi Chen et al. J Clin Transl Hepatol. .

Abstract

Background and aims: Hepatitis delta virus (HDV) is a defective virus and causes severe liver disease. Several HDV RNA assays have been developed, however the diagnostic efficacy remains unclear.This systematic review and meta-analysis aims to evaluate the diagnostic accuracy of HDV RNA assays to aid in the diagnosis of active hepatitis D.

Methods: The PubMed, Embase, and Cochrane Library databases were systematically searched from the beginning to June 31, 2022. Information on the characteristics of the literature and data on sensitivity, specificity, and area under curve (AUC) of the receiver operating characteristic (ROC) were extracted. Stata 14.0 was used for meta-analysis of the combined sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio.

Results: A total of 10 studies were included in the meta-analysis. The summary sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of HDV RNA assays for HDV diagnosis were 0.92 (95% CI: 0.87-0.95), 0.90 (95% CI: 0.86-0.93), 7.74 (95% CI: 5.31-11.29), 0.10 (95% CI: 0.06-0.18) and 99.90 (95% CI: 47.08-211.99), respectively. The AUC of the pooled ROC curve was 0.95 (95% CI: 0.92-0.96).

Conclusions: The results show that HDV RNA assays had high diagnostic performance. However, that is limited by the number and quality of studies. Standard protocols for the development of assays by manufacturers and larger studies on the use of the assays are needed.

Keywords: Diagnosis; Hepatitis delta virus; Hepatitis viruses; Sensitivity; Specificity.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Flowchart of literature identification.
Fig. 2
Fig. 2. Quality assessment of the study.
(A) Risk of bias and applicability concerns graph. (B) Risk of bias and applicability concerns summary.
Fig. 3
Fig. 3. Diagnostic accuracy of the use of HDV RNA assays for detection of hepatitis D-RNA.
(A) Forest plot of sensitivities and specificities of the use of HDV RNA assays for detection of hepatitis D-RNA. (B) SROC curve of HDV RNA assays diagnostic value. HDV, hepatitis delta virus; SROC, summary receiver operating characteristic.
Fig. 4
Fig. 4. Sensitivity analysis and Deek’s funnel plot asymmetry test to assess publication bias.
(A) Sensitivity analysis. (B) Deek’s funnel plot asymmetry test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Zhang Z, Urban S. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies. J Hepatol. 2021;74(3):686–699. doi: 10.1016/j.jhep.2020.11.032. - DOI - PubMed
    1. Yardeni D, Koh C. Bulevirtide for HBV and HDV infections. Drugs Today (Barc) 2021;57(7):433–448. doi: 10.1358/dot.2021.57.7.3283861. - DOI - PubMed
    1. Tseligka ED, Clément S, Negro F. HDV Pathogenesis: Unravelling Ariadne’s Thread. Viruses. 2021;13(5):778. doi: 10.3390/v13050778. - DOI - PMC - PubMed
    1. Netter HJ, Barrios MH, Littlejohn M, Yuen LKW. Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin. Front Microbiol. 2021;12:652962. doi: 10.3389/fmicb.2021.652962. - DOI - PMC - PubMed
    1. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378(9785):73–85. doi: 10.1016/S0140-6736(10)61931-9. - DOI - PubMed